Key result
Adenosine-detected latent accessory pathway conduction is not significantly linked to 6-week recurrence.
Why the study?
Despite successful radiofrequency ablation in pediatric accessory pathways, early recurrence may occur from latent conduction, prompting evaluation of whether adenosine testing can detect latent conduction and substitute the traditional 30-minute observation period.
Does the adenosine test predict early recurrence after successful accessory pathway ablation in pediatric patients?
Cohort (n=52)
Does the adenosine test predict early recurrence after successful accessory pathway ablation in pediatric patients?
The adenosine test effectively identifies latent accessory pathway conduction after pediatric ablation and may predict a higher risk of recurrence at 6 weeks.
Answers are grounded in this paper and cite their sources.
May signal higher early recurrence risk but should not change practice; leaves open need for larger validation.
Background Radiofrequency ablation of atrioventricular accessory pathways (AP) is highly effective in pediatric patients with Wolff–Parkinson–White syndrome or concealed APs. Despite procedural success, early recurrence may occur due to latent conduction. The adenosine test can unmask residual or concealed conduction, potentially allowing earlier termination of the procedure without the conventional 30-minute post-ablation observation. Objective This study evaluated the role of the adenosine test in detecting latent AP conduction following apparently successful ablation in children and assessed whether adenosine administration could substitute the traditional observation period. Methods A prospective cohort of 52 pediatric patients undergoing successful AP ablation was studied. Adenosine was administered 5–10 minutes post-ablation after electrophysiologic confirmation of AP block. Transient adenosine-induced conduction prompted immediate additional ablation until the test became negative. Early recurrence was monitored via surface ECG 30–60 minutes post-procedure and at a 6-week follow-up. The incidence of adenosine-induced latent conduction and recurrence was analyzed. Logistic regression was used to calculate odds ratios (OR) for 6-week recurrence. Results Latent AP conduction was detected in 7/52 patients (13%) by the adenosine test. No significant difference was observed between overt and concealed APs among adenosine-positive cases (p=0.347). Only one patient experienced a 30-minute recurrence among overt pathways. At 6 weeks, recurrence was 7.5-fold higher in adenosine-positive patients compared to adenosine-negative patients (OR 7.52, 95% CI 0.95–59.69, p=0.056). AP localization also showed trends toward increased recurrence: right-sided pathways (OR 6.24, 95% CI 0.69–56.10, p=0.102) and septal pathways (OR 4.71, 95% CI 0.64–34.83, p=0.129). No significant associations were found with sex or underlying diagnosis. Conclusions The adenosine test effectively identifies latent AP conduction after pediatric ablation and may predict higher recurrence risk. Although it can potentially replace the 30-minute observation period, borderline increased 6-week recurrence in adenosine-positive and certain pathway localizations suggests that careful post-procedural follow-up remains essential.
No takes yet. Share an insight, caveat, or question.
Mladoniczky et al. (2026) conducted a cohort in Wolff-Parkinson-White syndrome or concealed accessory pathways (n=52). Adenosine-positive test result (latent conduction) vs. Adenosine-negative test result was evaluated on 6-week recurrence (OR 7.52, 95% CI 0.95-59.69, p=0.056). Latent accessory pathway conduction detected by the adenosine test was associated with a 7.5-fold higher odds of 6-week recurrence compared to a negative test (OR 7.52; 95% CI 0.95-59.69; p=0.056).
Synapse has enriched 10 related papers. Consider them for comparative context: